<VariationArchive RecordType="classified" VariationID="16489" VariationName="NM_000146.4(FTL):c.458dup (p.His153fs)" VariationType="Duplication" Accession="VCV000016489" Version="3" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2022-12-11" DateCreated="2017-07-22" MostRecentSubmission="2022-10-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="31528" VariationID="16489">
      <GeneList>
        <Gene Symbol="FTL" FullName="ferritin light chain" GeneID="2512" HGNC_ID="HGNC:3999" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q13.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="48965309" stop="48966879" display_start="48965309" display_stop="48966879" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="49468565" stop="49470135" display_start="49468565" display_stop="49470135" Strand="+" />
          </Location>
          <OMIM>134790</OMIM>
          <Haploinsufficiency last_evaluated="2013-08-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FTL">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2013-08-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FTL">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000146.4(FTL):c.458dup (p.His153fs)</Name>
      <CanonicalSPDI>NC_000019.10:48966664:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>19q13.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="48966664" stop="48966665" display_start="48966664" display_stop="48966665" variantLength="1" positionVCF="48966664" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="49469921" stop="49469922" display_start="49469921" display_stop="49469922" variantLength="1" positionVCF="49469921" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>H153fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.48966665dup" Assembly="GRCh38">
            <Expression>NC_000019.10:g.48966665dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.49469922dup" Assembly="GRCh37">
            <Expression>NC_000019.9:g.49469922dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008152.1" sequenceAccession="NG_008152" sequenceVersion="1" change="g.6357dup">
            <Expression>NG_008152.1:g.6357dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012923.1" sequenceAccession="NG_012923" sequenceVersion="1" change="g.31689dup">
            <Expression>NG_012923.1:g.31689dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000146.4" sequenceAccession="NM_000146" sequenceVersion="4" change="c.458dup" MANESelect="true">
            <Expression>NM_000146.4:c.458dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000137.2" sequenceAccession="NP_000137" sequenceVersion="2" change="p.His153fs">
            <Expression>NP_000137.2:p.His153fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000146.3" sequenceAccession="NM_000146" sequenceVersion="3" change="c.458dupA">
            <Expression>NM_000146.3:c.458dupA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA281024" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="134790.0016" DB="OMIM" />
        <XRef Type="rs" ID="587776840" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000146.4(FTL):c.458dup (p.His153fs) AND Neuroferritinopathy" Accession="RCV000017953" Version="32">
        <ClassifiedConditionList TraitSetID="5415">
          <ClassifiedCondition DB="MedGen" ID="C1853578">Neuroferritinopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2009-06-01" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2009-06-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-07-22" MostRecentSubmission="2022-10-01">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12746423</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18854324</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301320</ID>
          <ID Source="BookShelf">NBK1141</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5415" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3088" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Neurodegeneration with brain iron accumulation 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BASAL GANGLIA DISEASE, ADULT-ONSET</ElementValue>
                <XRef Type="MIM" ID="606159" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Neuroferritinopathy</ElementValue>
                <XRef ID="156901" DB="GeneTests" />
                <XRef ID="Neuroferritinopathy/5169" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011638" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NBIA3</ElementValue>
                <XRef Type="MIM" ID="606159" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10686" />
                <XRef ID="10686" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Neuroferritinopathy is an adult-onset progressive movement disorder characterized by chorea or dystonia and speech and swallowing deficits. The movement disorder typically affects one or two limbs and progresses to become more generalized within 20 years of disease onset. When present, asymmetry in the movement abnormalities remains throughout the course of the disorder. Most individuals develop a characteristic orofacial action-specific dystonia related to speech that leads to dysarthrophonia. Frontalis overactivity and orolingual dyskinesia are common. Cognitive deficits and behavioral issues become major problems with time.</Attribute>
                <XRef ID="NBK1141" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301320</ID>
                <ID Source="BookShelf">NBK1141</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23447832</ID>
                <ID Source="BookShelf">NBK121988</ID>
              </Citation>
              <XRef ID="157846" DB="Orphanet" />
              <XRef ID="C1853578" DB="MedGen" />
              <XRef ID="MONDO:0011638" DB="MONDO" />
              <XRef Type="MIM" ID="606159" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="38232" SubmissionDate="2017-07-19" DateLastUpdated="2017-07-22" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="134790.0016_NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3" title="FTL, 1-BP DUP, 458A_NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3" />
        <ClinVarAccession Accession="SCV000038232" DateUpdated="2017-07-22" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2009-06-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of a French family with neuroferritinopathy (NBIA3; 606159), Devos et al. (2009) identified a 1-bp duplication (458dupA) in the FTL gene. The patients developed symptoms between 24 and 44 years of age. Presenting features included dystonia, causing writing difficulties or a gait disorder, followed by rapid progression to orofacial, pharyngeal, and laryngeal dystonia. L-DOPA was not effective. None developed spasticity, abnormal reflexes, or marked tremor. Three deceased family members developed cerebellar ataxia. All developed a moderate subcortical/frontal dementia. Other atypical features included a limitation of vertical eye movements and mild dysautonomia, including orthostatic hypotension, constipation, and urinary incontinence. Brain imaging showed iron deposition and cystic cavitation of the basal ganglia. Serum ferritin levels were decreased. The family had originally been thought to carry a different FTL mutation (460insA; 134790.0010) (Chinnery et al., 2003).</Attribute>
              <Citation>
                <ID Source="PubMed">18854324</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">12746423</ID>
              </Citation>
              <XRef DB="OMIM" ID="606159" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FTL" />
          </GeneList>
          <Name>FTL, 1-BP DUP, 458A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 458A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="134790.0016" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4996366" SubmissionDate="2022-07-27" DateLastUpdated="2022-10-01" DateCreated="2022-07-28">
        <ClinVarSubmissionID localKey="NM_000146.3:c.458dupA|OMIM:606159" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV002553190" DateUpdated="2022-10-01" DateCreated="2022-07-28" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="BookShelf">NBK1141</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000146.3:c.458dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1853578" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11864799</SubmissionName>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="38232" TraitType="Disease" MappingType="Name" MappingValue="NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3" MappingRef="Preferred">
        <MedGen CUI="C1853578" Name="Neuroferritinopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4996366" TraitType="Disease" MappingType="XRef" MappingValue="C1853578" MappingRef="MedGen">
        <MedGen CUI="C1853578" Name="Neuroferritinopathy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

